Antineoplastic agents are carcinogens and mutagens which may be inhaled, ingested, or absorbed by workers who handle these agents. However, the nature of the risk to workers from exposure to these drugs has not been clearly defined. No one can be pleased that workers are exposed to even small amounts of these drugs even though the degree of systemic absorption, if any, remains unknown. It is well known, however, that several of these drugs, including cis-platinum, mechlorethamine, actinomycin D, doxorubicin, and mitomycin C, have a direct effect on the skin, mucous membrane and eye causing local toxic and allergic reactions (Knowles & Virdon, 1980; Leyden & Sullivan, 1983; Olver & Schwarz, 1983) , The risk associated with the carcinogenic and mutagenic effects may indeed not be known for several years and it should be of major concern to those who handle the antineoplastic agents, those who employ these workers and to research scientists. The han-d1i~g of these agents during preparation or administration varies greatly from workplace to workplace. These agents are often prepared openly on the hospital unit, and frequently in clinics, or private physicians offices in areas not adequately ventilated.
In some facilities horizontal rather than vertical laminar flow hoods are used for drug preparation areas. The Safety Committee of the Memorial Sloan-Kettering Cancer Center has issued guidelines for personnel who handle cytotoxic drugs, and has concluded that horizontal flow hoods may represent a hazard to per-Many antineoplastic agents themselves are carcinogenic, mutagenic and teratogenic, and should be considered by workers as potentially hazardous substances. sonnel (Hoffman, 1980) . Horizontal hoods are designed so that filtered air travels horizontally through the cabinet and is able to carry aerosolized drug particles out of the hood onto personnel and into the room at large (Donner, 1978) . On the other hand, the use of vertical hoods, i.e., those which direct the air flow away from the worker, appear to offer some degree of protection (Anderson, Puckett, Dana, Nguyen, Theiss & Matney, 1982; Brier, Latiolais, Scheider, Moore, Bueschling & Wentworth, 1981) .
Disposal of excess medication or spillage (of the antineoplastic agent) is frequently accompl ished by pouring the substance down the sink, while needles, tubing, and syringes are often discarded with the usual trash. The use of gloves, masks, and hygienic measures during preparation and administration of these agents are of major concern. In a study by Tortorici (1980) , 25 questionnaires were mailed to designated Comprehensive Cancer Centers in the United States to determine the opinions and current practices concerning the handling of antineoplastic agents. Twenty-one respondents indicated their major concern was direct skin contact and inhalation of vapors; yet, only four centers reported that personnel wore gloves and masks, and only three centers used vertical hoods. Discarding of material was quite varied. This study clearly points out that few hospitals take precautions to protect their personnel from potential hazards. Stellman et al. (1985) conducted walkthroughs, staff interviews, and observa-tions of routine procedures for handling antineoplastic agents in five hospitals in order to assess drug handling practices. Nurses most frequently admixed and administered the agents followed by pharmacists and physicians. Results indicated inconsistent handling practices from practitioner to practitioner, minimal use of protective clothing and inappropriate installation of safety cabinets. In a survey of nurses who handle antineoplastic agents in a midwestern city, Valanis and Brown (1985) found an infrequent use of protective clothing, unavailability of laminar hoods for preparing the drug, and lack of standardized procedures for disposal of contaminated materials.
Recommendations and guidelines for the safe handling of antineoplastic agents have been issued by several agencies and groups (Anderson et aI., 1982; Harrision, 1981; OSHA, 1986; Zimmerman et aI., 1981) . Areas addressed in the scope of the guidelines vary and may include preparation, handling and disposal of antineoplastic agents, the use of personal protective equipment, special procedures for acute exposure and spills, and training of personnel. Medical surveillance, at risk conditions (e.g., pregnancy) and handling of substances outside the hospital environment are discussed minimally if at all. OSHA has recently issued guidelines for handling these SUbstances, however, data are not available as to their use.
Reports in the literature indicate concern for personnel who handle antineoplastic agents because of the potential for health hazards as a result of exposure to these substances (Rogers, 1986) . Although the results of studies have been inconsistent, investigators report evidence of systemic absorption via inhalation, skin contact and ingestion as manifested by urinary mutagenicity, sister chromatid exchanges, liver damage, and more recently an increase in spontaneous abortions to exposed female workers (Selevan, Lindbohm, Polsci, Hornug & Hemminki, 1985) .
More than 65% of employees who work in the health care industry are women and the majority, as reported by the Bureau of Labor Statistics (1983) , are in childbearing ages. The risk of fetal insult and of developing acute and longterm health problems cannot be ignored and worker safety must be a priority. Many antineoplastic agents themselves are carcinogenic, mutagenic and teratogenic, and should be considered by workers as potentially hazardous substances. Personal protective equipment is not always available, used or may be inadequate.
BACKGROUND
It has been known for more than 70 years that workers handling various chemical compounds, such as coal tars, chromium compounds and aromatic amines have an increased incidence of skin, urinary and lung cancers. Exposure to these chemicals may result in DNA damage which in turn may hamper or alter DNA replication. Damage to somatic or germinal cells can result in cancer or mutational events that can affect future generations. Humans do possess enzymes that may repair damage to genetic material; however, if
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damage goes unrepaired or if lesions are not totally removed from the DNA, replication may bear a miscoded message. The lesions left on the DNA by such a process are mutations which may result in neoplastic or chromosomal aberrations (Devoret, 1979) . Several in vitro tests, such as the Ames assay, have been developed to identify cellular mutationswhich may occur as a result of exposure to mutagens (Ames, McCann & Yamasaki, 1975) .
It is well known that many antineoplastic agents are carcinogens in experimental systems and second neoplasms, organ dysfunction, and teratogenicity have been reported in patients receiving cancer chemotherapy (Chabner, 1977; Reimer, Hoover, Frawmeni & Young, 1977) . Several investigators have reported the development of bladder cancer in patients following cyclophosphamide therapy (Dale & Smith, 1974; Wall & Clausen, 1975) . Horning et al. (1981) and Karp (1983) have reported conflicting results on reproductive outcomes to women treated with long-term chemotherapy Epidemiologic data have demonstrated that a latency period of at least five and frequently 20 years elapses between carcinogenic exposure and cancer detection. In addition, a low dose exposure generally produces a longer latency period (Hoover & Fraumeni, 1981) . Current federal policies state that it is unacceptable to allow potential carcinogenic exposure to continue until human cancer actually occurs. To date, there have been no scientifically documented adverse effects among personnel who handle these drugs but the question of long-term mutational or carcinogenic effects remains unanswered.
Recent studies, designed to measure urine mutagenic activity and drug excretion levels, have been conducted to determine if workers who handle these agents are at risk of exposure. Cytogenic studies and anecdotal notes have been reported in the literature, the results of which are speculative and conflicting. An early study by Falck, Grohn, Sorsa, Vanino, Heninonen and Holsti (1979) reported the results of mutagenic activity in random samples of urine from each of ten patients receiving chemotherapy, seven nurses administering these drugs and 32 unexposed controls who were psychologists and office clerks. All patients exhibited mutagenicity in their urine. Two urine samples were collected from each nurse, the first sample during the work week and the second sample on the morning after a free weekend. Most of the nurses exhibited mutagenic activity in their urine concentrates with significantly less mutagenicity after a duty-free weekend. The urine of controls was non-mutagenic. A significant difference between exposed and unexposed subjects was reported. All study subjects were non-smokers.
In a study reported by Anderson et al. (1982) and Nguyen et al. (1982) , six pharmacists who prepared intravenous admixtures in both horizontal and vertical flow hoods using gloves and masks individually collected 24-hour urine samples during an eight-day period. Three pharmacists who did not handle any drugs served as controls. Urinary mutagenicity, as measured by the Ames assay, was observed in all personnel during periods when they prepared anti-
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neoplastic admixtures in horizontal flow hoods both with and without protective equipment. When admixtures were prepared in the vertical flow hoods by personnel wearing gloves, no mutagenic activity was detected. The control group urine was non-mutagenic. A study reported by Gibson, Gompertz and Hedworth-Whitty (1984) indicated a lack of mutagenic urine in two nurses handling cytotoxic drugs and Hoffman found no urine mutagenic activity in nurses who administered but did not prepare the agents. In other studies investigators (Hirst, Mills, Tse, & Levin, 1984; Jagun, Ryan & Waldron, 1982; Venitt, Crofton-Sleigh, Hunt, Speechly & Briggs, 1984) have reported the urinary excretion of cyclophosphamide, thioethers (a measure of alkylating agents), and platinum respectively in nurses who handled the antineoplastic agents.
Testing for sister chromatid exchanges (SCE) has been used increasingly to detect mutagen exposure (Wolff, 1983) . Several studies have been reported which cite the increase in frequency of sister chromatid exchanges in patients treated with cytotoxic agents and in personnel who handle these drugs. Musilova, Michalova & Urban (1979) examined blood samples of patients treated with cyclophosphamide, busulfan, and adriamycin. All patients showed significant increases in the number of SCE which remained elevated for up to five months post treatment. Studies by Waksvik et al. (1981) , Norppa et al. (1980), and Nikula et al. (1984) report an increased frequency of sister chromatid exchanges in nurses who handled antineoplastic agents, while Stiller et al. (1983) found no significant elevations in chromosomal aberrations.
Anecdotal descriptive case reports made separately by Ladik et al. (1980) and Crudi (1980) indicated that person-nel who worked with antineoplastic agents experienced various somatic complaints. Symptoms of lightheadedness, dizziness, facial flushing, coughing while lying down, nausea, headaches, hair loss, and nasal sores were reported. Wilson at Walter Reed Army Hospital indicated, however, that nine pharmacists handling the antineoplastic agents reported no unusual symptoms and of the two who were tested for mutagenic urine activity neither were positive. Although not documented, this was attributed to safe handling practices.
In a study conducted by Rogers (1985) , a population of nurses who were exposed to antineoplastic agents was examined to determine if a health hazard existed to this population. A crosssectional design was used in which interview data, drug handling methods, and urine sample analyses were compared from nurses who prepared or administered antineoplastic agents with an unexposed population of nurses. The exposed nurses were significantly more likely to have mutagenic urine activity (p = <0.001), symptomatic complaints (p = <0.05), and spontaneous abortions (p =~0.05). As part of this larger study, the influence of work practices, methods of handling antineoplastic agents and the use of personal protective equipment was assessed in relation to these outcomes. The purpose of this paper is to report those findings.
METHODS AND MATERIALS
The target population for the study were nurses who handled the antineoplastic agents and who worked or resided in the Maryland area. Contact was made with the national and local Oncology Nursing Societies to ascertain their interest in, and obtain their support for, this study The research project was presented to members of the Maryland Oncology Nursing Society (MONS) and, after endorsement of the project, membership lists were supplied to the investigator. In addition, telephone contact was made to all private oncologists' offices and oncology clinics in the Baltimore metropolitan area to identify chemotherapy nurses who worked in these settings. A total N = 165 was ascertained and potential study subjects were invited by letter to participate in the study Two mailings and telephone follow-up to these oncology nurses resulted in 126 (75%) responses to participate in the study Two nurses refused to participate and 37 nurses were unlocatable.
Comparison group subjects were community health nurse members randomly selected from membership lists of the district nurses' association. These nurses did not handle antineoplastic agents. One hundred-eighty subjects were contacted by mail and 117 (65%) responses were returned.
Subjects were considered eligible to participate in the study if they worked a minimum of three consecutive days, had two consecutive duty-free days, and had not been diagnosed with cancer. Fifty-nine exposed subjects (i.e., those who handled antineoplastic agents) and 64 unexposed subjects met these criteria.
The questionnaire was developed by the investigator and reviewed for content validity by oncology nurse experts. Modifications of the instrument were made after pilot testing by nurses in the target population and local community health nurses who were ineligible to participate in the study Questionnaires were administered by trained interviewers after obtaining informed consent. Information obtained included: • demographic characteristics; • occupational history including place of employment, length of time working in oncology areas, use of protective clothing, and hygiene factors; • health history and general health status indicating recent illnesses and symptoms; • pregnancy history and reproductive outcomes; • alcohol and medication intake; • present and past smoking history; • frequency and duration of handling antineoplastic agents. In addition to the questionnaire, each. study subject was asked to keep a daily log, during the week of the study, of medications prepared for and administered to patients, the route of administration and number of doses given. Personal information on the number of cigarettes smoked per day, medications taken, and alcohol consumed was also recorded. Exposed subjects collected two 24-hour urine samples, one sample on the last day of the work period and one sample at the end of the duty-free period while unexposed subjects collected one 24-hour sample at the end of the work week. Each urine sample was collected in 2000-ml labeled polyethylene urine containers, and then transported on ice by the investigator to the differences were statistically significant at P = 0.0001. Use of personal protective measures of these subjects was examined by type of employment. Although few in number, subjects who worked in hospital settings were more likely to use protective equipment compared to clinic and office personnel More than 20% of hospital subjects used masks (four) and gloves (five) and 16% (three) used protective clothing. Only one of the clinic subjects and none of the private office nurses wore masks. Similarly, glove use was less in the clinic and agents. Of the 24 subjects who had used any types of protective measures at all, 75% (18) had employed these techniques for less than twelve months. Subjects who worked in clinics and private physicians' offices were at least three times more likely to prepare antineoplastic agents than were hospital based subjects. When comparing the data between employment groups of subjects, those who worked in clinics and private offices accounted for 86% (12 and 12) of all subjects who prepared these agents while hospital subjects accounted for only 14% (Table 4 ). These
DEMOGRAPHIC CHARACTERISTICS OF THE STUDY POPULATION

RESULTS
The sample for this study consisted of 59 exposed subjects who handle antineoplastic agents and 64 unexposed comparison subjects. The study population was all female but two and all white but two (97%) with similar distribution in each group. The mean age of the exposed group was 33.8 with a range from 22 to 54 and the comparison group had a mean age of 44.9 with a range from 24 to 63 years (Table 1) .
The distribution of types of employment within each subject group can be found in Table 2 . Thirty-two percent (19) of exposed subjects worked in hospital oncology units, 48% in oncology clinics and 20% in private oncology offices while 67% of comparison subjects worked in community health agencies, 17% (11) worked in schools and 16% (ten) worked in hospitals or other community facilities. Most of the exposed and comparison subjects were staff nurses, clinical nurse specialists, or office nursing personnel. These non-supervisory personnel comprised 88% (52) of exposed and 73% (47) of comparison subjects.
In addition to frequency of handling and duration of exposure to antineoplastic agents, methods of handling and disposing of these drugs and use of personal protective measures were examined. These are displayed in Table  3 . Forty-seven percent (28) of subjects prepared and administered antineoplastic agents while 53% (31) only administered these drugs. Although 40% (24) of subjects Indicated that they did use gloves at least some of the time when" preparing or administering these agents, half of these subjects wore gloves only during nitrogen mustard preparation. Approximately 90% indicated they never used protective clothing, such as gowns, laboratory coats or aprons or masks, even though the efficacy of masks or specific types of masks has not been clearly defined. Laminar flow hoods were not used by any subjects during preparation of these National Cancer Institute-Frederick Cancer Research Facility (NCI-FCRF) where they were stored frozen and then tested for mutagenicity using the Ames assay The Ames assay uses strains of Salmonella bacteria as an indicator of exposure to chemical mutagens. The assay method used has been described by Ames and will not be discussed here (Ames et al., 1975) , private office nurse groups Use of protective clothing for oncology clinic nurses was similar to that of the hospital nurses but was non-existent for private office nurses. These data are illustrated In Table 5 All exposed subjects were 7.5 times more likely to have positive mutagenic urine results as compared to all unexposed subjects. Thirty-six of 59 (61%) exposed subjects had mutagenic urine activity as compared to 11 of 64 (17%) unexposed subjects (odds ratio = 7.5, P = 0.001). Insofar as cigarette smoke is a known mutagen, a comparison of nonsmoking subjects showed that 58% (31) of the exposed and only 5% (three) of the unexposed subjects had positive mutagenic urine (odds ratio = 244, p = 00001) Indicating a 24-fold Increase of mutagenic urine for exposed nonsmokers.
Subjects who used either gloves, masks or protective clothing were less likely to have a mutagenic response than those who did not use these protective devices but the differences were not statistically significant Two Important factors influencing Urinary mutagenicity were the method of handling (i.e.. preparation or administration) and the number of doses of antineoplastic agents handled by the subjects. Twenty-two 09%) subjects who prepared and/or administered agents compared 14 (45%) subjects who only administered antineoplastic agents were significantly more likely to have mutagenic urine When examining non-smokers separately, 80% (20) of those who prepared agents compared to 39% (11) of those who administered agents had positive urine mutagenicity These differences were statistically significant (Table 6) , With respect to the number of doses of antineoplastic agents handled by subjects, results showed that 93% of subjects who gave more than 40 doses of antineoplastic agents had mutagenic urine as compared to 31% of subjects who gave less than 12 doses of antineoplastic agents during the study week.
DISCUSSION
The exposed subjects who participated In this study were oncology nursing personnel who worked In a variety of settings, including hospital oncology units (32%), oncology clinics (48%), and private oncologists' offices (20%). The unexposed comparison subjects were community health nurses who worked primarily In community health centers and schools or In industries and hospitals. Subject handling of antineoplastic agents was assessed in relation to worker characteristics, types of employment, work activities, work patterns, and use of personal protective measures. These variables were then examined in relation to urinary mutagenicity Exposed subjects were significantly more likely to have mutagenic urine ectivity as compared to unexposed nurses. With respect to the number of doses of antineoplastic agents handled by subjects, results showed that 93% of subjects who gave more than 40 doses had mutagenic urine as compared to 31% of subjects who gave less than 12 doses of antineoplastic agents dUring the study week.
It was hvpothesized that if subjects used personal protective measures the risk of urine mutagenicity would be less than for those subjects who did not employ these practices. Most subjects chose not to use personal protective measures even though the equipment was readily available. However, if protective equipment was used it was generally gloves Only 40% of all exposed subjects used gloves and only 20% reported using them most all of the time. Even though hospital subjects reported using masks significantly more frequently than either oncology clinic subjects or office personnel, only four hospital subjects and one clinic subject ever used masks. No subjects who prepared antineoplastic agents used laminar flow hoods although the equipment was available to some of them. Anderson et al. (1982) have previously indicated that vertical hoods provided workers with protection from exposure to antineoplastic agents. In this study, subjects who were more likely to use personal protective measures were somewhat less likely to have a positive mutagen response but the differences were not statistically significant.
It was thought that subjects who prepared the agents were probably at greater risk of exposure since preparation of the agent involves mixing and aerosolization of the substance when clearing the syringe. All subjects who prepared the agents also administered the agents. Those who only administered the agent received the drug already prepared from the pharmacy All subjects who worked in private oncologists' offices both prepared and administered antineoplastic agents compared to 43% of clinic subjects and 21% of hospital subjects. The results of urine tests supported the hypothesis that subjects who prepared the antineoplastic agents were at significantly greater risk than those who only administered the agent A significant positive association was found between urine mutagenic activity and the number of doses of antineoplastic agents given by exposed subjects.
Several investigators have reported increased urine mutagenic activity and chromosomal aberrations among oncology personnel who handle the antineoplastic agents (Anderson et al., 1982; Bos, Lenaars, Theuws, & Henderson, 1982; Falck, Grohn, Sorsa, Vaninio, Heinonen & Holisti, 1979; Norppa, Sorsa, Vaini, Grohn, Heinonen, Holisti & Nordman, 1980; Stucker, Hirsch, Doloy, Bastic-Sigeac & Hemon, 1986; Waksvic et al., 1981) . Even though the amount of the drug absorbed in this manner is probably very small, the exposure period may be long. Other investigators have reported Iiver damage, somatic complaints, and increased spontaneous abortions (Crudi, 1980; Rogers, 1985; Selevan, Lindbohm, Polsci, Hornung & Hemminki, 1986; Sotaniemi et aI., 1983) It is therefore prudent to exercise caution when handling these drugs.
The use of self-protection by nurses in this study was minimal. These results are consistent with the findings of Stellman Valanis and Brown (1985) and Crudi (1980) . Anderson et al. (1982) reported, however that preparation of cytotoxic drugs in vertical laminar flow hoods reduced urine mutagenic activity levels. These findings were supported by Kolmodin-Hedman et al (1983) . The reasons for this lack of concern have not been documented, however it is suggested that health care professionals view themselves as being immune from work-related hazards (Office of Occupational Medicine, OSHA, 1986). Several institutions and agencies have issued guidelines for personnel who handle the antineoplastic agents (AMA, 1985; Hillcoat, Levi, & Snydet 1983; Le Roy, Roberts, & Theisen, 1983; Oncology Nursing Society, 1984; OSHA, 1986; National Study Commission on Cytotoxic Exposure, 1983; Zimmerman, Larson, Bar- Several studies have been reported which cite the increase in frequency of sister chromatid exchanges in patients treated with cytotoxic agents and in personnel who handle these drugs. kley & Gallelli, 1981) . These guidelines discuss the use of personal protective equipment, i.e., gloves, hoods, clothing, face shields and goggles, methods of handling and disposal of antineoplastic agents and waste materials, and training of personnel. Because the chemotherapeutic agents have been shown to have carcinogenic, mutagenic and teratogenic properties, in animal and patient studies it is imperative that recommended precautionary measures be observed. Personnel who handle these substances should be given appropriate and regular training and encouraged to use personal protective measures.
METHOD OF HANDLI~G ANTI~EOPLASTIC AGE~TS ACCORDI~G TO TYPE OF EMPLOYME~T OF EXPOSED SUBJECTS
The results of this study suggest that subjects exposed to antineoplastic agents are at significantly greater risk of urine mutagenic activity as compared to the unexposed population. The data show that exposed subjects with positive urine outcomes are significantly more likely to work in clinics and private oncologists' offices and more likely to prepare (and administer) the antineoplastic agents rather than only administer these agents. This is not to suggest that hospital oncology nurses are not at risk but rather the level of exposure may be less. The data indicate that very few nurses use personal protective equipment and that lack of use of these protective measures may be a risk factor. Nurses who handle a greater number of doses of antineoplastic agents also were more likely to have mutagenic urine.
Further research which examines the health outcomes of workers exposed to antineoplastic agents, observation of work practices of these employees, and behavioral rationale for use or non-use of protective measures is necessary It is prudent to recommend that careful consideration be given to examining explicitly the work practices and patterns of personnel exposed to antineoplastic agents and to institute appropriate interventions, at least sufficient to prevent biological indications of exposure. Workers who handle these agents should also be strongly cautioned regarding their smoking and hygienic practices. Workers and management alike should be informed of the potential hazard which exists.
